Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,377,919
+$1,921,214 QoQ
Shares Held
3,650
+36.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
#1,814
of 4,605 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 30%
Shared 0%
None 70%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Keel Point, LLC holds $22,441,479 across 10 Drug Manufacturers - General names. LLY ranks #3 (19.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
24,474 | $6,215,661 | |
| 2 | MRK |
Merck & Co., Inc.
|
36,633 | $4,707,340 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
3,650 | $4,377,919 | |
| 4 | ABBV |
AbbVie Inc.
|
11,997 | $3,018,925 | |
| 5 | NVS |
Novartis AG
|
6,229 | $976,208 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,068 | $892,971 | |
| 7 | AMGN |
Amgen Inc
|
2,204 | $798,112 | |
| 8 | AZN |
Astrazeneca PLC
|
3,042 | $576,824 |
All Filings in LLY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,377,919 | 3,650 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,456,705 | 2,671 | Shares | Sole | 2026-06-01 | |
| 2025-12-31 | $4,390,068 | 4,085 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,753,667 | 3,609 | Shares | Sole | 2025-12-16 | |
| 2025-06-30 | $2,796,953 | 3,588 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,917,940 | 3,533 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,316,772 | 3,001 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,566,568 | 2,897 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,733,342 | 3,019 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,731,738 | 2,226 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,200,815 | 2,060 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $1,080,168 | 2,011 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $929,049 | 1,981 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $633,609 | 1,845 | Shares | Sole | 2023-04-03 | |
| 2022-12-31 | $684,486 | 1,871 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $549,371 | 1,699 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $546,976 | 1,687 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $523,770 | 1,829 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $506,587 | 1,834 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $448,468 | 1,941 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $344,739 | 1,502 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $279,856 | 1,498 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $213,582 | 1,265 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $207,079 | 1,399 | Shares | Sole | 2020-11-18 | |
| No filing history on record for this holder in this stock. | ||||||